Publication | Open Access

Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials

OncologyLux-lung 3Lux-lung 6PathologyBronchial NeoplasmCancer TreatmentMedicineRadiation OncologyLung CancerMolecular OncologyLux-lung 7